Retatrutide: The Triple-Agonist Mechanism, Trial Data, and Clinical Candidacy
Retatrutide explained in depth: how GLP-1, GIP, and glucagon receptor agonism work together, what the phase 2 and phase 3 trial data actually shows, who is a clinical candidate, and what monitoring is required.
Dr. Michael Ackland ·
11 min read